Photodynamic therapy Clinical Trials in Arlington, TX
Arlington, Texas hosts paid clinical trials testing Photodynamic therapy when studies are open for enrollment. Trials typically compensate participants for time, travel, and study visits, and many also provide study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Arlington
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
1 clinical trial testing Photodynamic therapy
Top Research Study Locations in Arlington
Researchers run research studies in Arlington, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Texas at Arlington | Quality of Life, Aging, Alcohol Abstinence | 6 |
| Texas Clinical Research Institute, LLC | Liver Cirrhosis, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis | 4 |
| UPNT Research Institute | Bladder (Urothelial, Transitional Cell) Cancer, Incontinence, Urinary, NMIBC | 4 |
| Texas Oncology - DFW | Advanced Non-Small Cell Lung Cancer, Breast Cancer, Breast Neoplasms | 3 |
| Arlington Research Center, Inc | Alopecia Areata, Atopic Dermatitis | 3 |
| Arlington Center for Dermatology | Chronic Spontaneous Urticaria (CSU), Plaque Psoriasis | 2 |
| Arlington Research Center | Dermatitis Atopic | 2 |
| GSK Investigational Site | Liver Diseases, Alcoholic, Non-alcoholic Fatty Liver Disease | 2 |
| The Center for Cancer and Blood Disorders | Metastatic Castration-resistant Prostate Cancer, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma | 2 |
| UPNT Research Institute, LLC | High-Risk Non-Muscle-Invasive Bladder Cancer, Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma | 2 |
| University of Texas Arlington | Aging, Peripheral Artery Disease (PAD) | 2 |
| Urology Partners of North Texas | Erectile Dysfunction (ED), Non-muscle Invasive Bladder Cancer | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH - Nonalcoholic Steatohepatitis | 1 |
| Arlington | Endometriosis, Uterine Fibroids | 1 |
| Arlington Nephrology, PLLC. | Diabetic Kidney Disease (DKD) | 1 |
| Arlington Research Center, Inc. | Hidradenitis Suppurativa | 1 |
| Artiva Investigational | IIM, Idiopathic Inflammatory Myopathies (IIMs), Myositis | 1 |
| Enveda Investigative Site | Atopic Dermatitis (AD) | 1 |
| Galderma Investigational | Systemic Sclerosis | 1 |
| Investigative Site | CLE, Cutaneous Lupus Erythematosus (CLE), SLE | 1 |
| Investigator | Focal Segmental Glomerulosclerosis | 1 |
| Local Institution - 007-879-A | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Local Institution - 007-879-B | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
Active & Upcoming Studies in Arlington (2026)
Recruiting trials in Arlington grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (14 active studies)
- A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · Phase 1 · UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
Cardiovascular (4 active studies)
- A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. · Phase 2 · AstraZeneca
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Eye & vision (3 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
Mental health & behavior (2 active studies)
- Exploring Virtual Reality Adventure Training Exergaming · The University of Texas at Arlington
- Effects of Exercise and Virtual Reality on Depression · The University of Texas at Arlington
Diabetes & metabolic (2 active studies)
- A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH · Phase 3 · GlaxoSmithKline
- A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH · Phase 3 · Akero Therapeutics, Inc
Neurology & pain (1 active study)
- Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study · The University of Texas at Arlington
Common conditions studied in Arlington
- Atopic Dermatitis (3 active studies)
- Advanced Non-Small Cell Lung Cancer (2 active studies)
- Aging (2 active studies)
- Benign Prostatic Hyperplasia (2 active studies)
- Breast Neoplasms (2 active studies)
- Chronic Kidney Disease and Hypertension (2 active studies)
Leading research sponsors in Arlington
- The University of Texas at Arlington
- Pfizer
- AbbVie
- AstraZeneca
- Boehringer Ingelheim
Frequently asked questions
How many paid clinical trials are currently recruiting in Arlington?
There are approximately 65 recruiting clinical trials in Arlington, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Arlington pay participants?
Most recruiting trials in Arlington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Arlington?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Arlington?
The most common conditions under active study in Arlington include Atopic Dermatitis (3), Advanced Non-Small Cell Lung Cancer (2), Aging (2), Benign Prostatic Hyperplasia (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Arlington?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Arlington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Arlington?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Arlington?
Recruiting research sites in Arlington include University of Texas at Arlington, Texas Clinical Research Institute, LLC, UPNT Research Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Arlington right now?
The largest active categories in Arlington are Cancer & tumors (14), Cardiovascular (4), Eye & vision (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.